Invitrogen™ Human TMEM70 Synthetic Peptide
TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.
- Gene ID (Enter)
- 54968
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9BUB7
- Common name
- Human TMEM70
- Brand
- Invitrogen
TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.
TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.
TMEM70 is a recently identified mitochondrial protein that is thought to play a role in the biogenesis of the ATP synthase in higher eukaryotes. Mutations in this gene result in early neonatal onset of hypotonia, hypertrophic cardiomyopathy, lactic acidos and 3-methylglutaconic aciduria (3-MGC-uria), and usually cause death within the first six weeks of life, although some patients survive much longer. Little is known of the role of TMEM70, but it is conserved across multicellular eukaryotic organisms. It contains a conserved DUF1301 domain and two putative transmembrane regions.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15265029 |
| Specifications | |
| Gene ID (Enter) | 54968 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9BUB7 |
| Common name | Human TMEM70 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TMEM70 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1029 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |